Avandia Panel Rife with Conflict

Avandia Panel Rife with Conflict

The news of Avandia panelist Dr. Abraham Thomas confessing a potential conflict comes after another panelist Dr. David Capuzzi was discovered to be a paid speaker for GSK, the drug…

More in Health >
FDA Panel recommends keeping Avandia on the market

FDA Panel recommends keeping Avandia on the market

In a split decision vote 20 to 12, an FDA panel has decided to leave diabetes drug Avandia on the market despite recent studies suggesting that Avandia can increase heart…

More in Health >